CONTRACT MODIFICATION AND TERMINATION AGREEMENTContract Modification and Termination Agreement • March 15th, 2002 • Pharmacia & Upjohn Inc • Pharmaceutical preparations • New York
The foregoing opinion is limited to the Federal laws of the United States and the laws of the State of New York, and we are expressing no opinion as to the effect of the laws of any other jurisdiction.
JOINT FILING STATEMENTJoint Filing Statement • March 15th, 2002 • Pharmacia & Upjohn Inc • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock, $0.01 par value, of Miravant Medical Technologies, and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13D.
